Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3119
+0.0019 (0.61%)
Mar 11, 2026, 2:05 PM EDT - Market open

Cue Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
7.19.295.491.2514.943.15
Revenue Growth (YoY)
-25.51%69.16%340.96%-91.67%373.68%-8.79%
Gross Profit
7.19.295.491.2514.943.15
Selling, General & Admin
16.8114.5916.6816.1717.3114.65
Research & Development
28.436.340.838.5841.3533.55
Other Operating Expenses
0.06-0.090.16-0.28--
Total Operating Expenses
45.2650.7957.6454.4758.6548.2
Operating Income
-38.16-41.5-52.15-53.23-43.71-45.04
Interest Income
0.881.622.660.930.050.46
Interest Expense
-0.4-0.8-1.25-0.71--
Total Non-Operating Income (Expense)
0.480.831.420.220.050.46
Pretax Income
-37.68-40.67-50.73-53.01-43.67-44.58
Provision for Income Taxes
----0.50.21
Net Income
-37.68-40.67-50.73-53.01-44.16-44.78
Net Income to Common
-37.68-40.67-50.73-53.01-44.16-44.78
Shares Outstanding (Basic)
865646363129
Shares Outstanding (Diluted)
865646363129
Shares Change (YoY)
74.11%23.11%28.35%13.95%9.05%30.16%
EPS (Basic)
-0.46-0.72-1.11-1.49-1.41-1.56
EPS (Diluted)
-0.46-0.72-1.11-1.49-1.41-1.56
Free Cash Flow
-29.82-36.4-39.96-41.98-39.75-33.09
Free Cash Flow Per Share
-0.35-0.65-0.87-1.18-1.27-1.15
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-537.49%-446.86%-949.89%-4275.10%-292.56%-1427.96%
Profit Margin
-530.75%-437.97%-924.10%-4257.83%-295.56%-1419.79%
FCF Margin
-419.97%-391.89%-727.89%-3371.65%-266.04%-1049.01%
EBITDA
-37.78-41.1-51.59-52.3-42.45-43.99
EBITDA Margin
-532.17%-442.59%-939.76%-4201.04%-284.14%-1394.44%
EBIT
-38.16-41.5-52.15-53.23-43.71-45.04
EBIT Margin
-537.49%-446.86%-949.89%-4275.10%-292.56%-1427.96%
Effective Tax Rate
-0.00%0.00%0.00%-1.13%-0.46%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q